Lupin Digital Health, India's pioneer evidence-based cardiology digital therapeutics (DTx) platform, and the American College of Cardiology (ACC), a global leader in the practice of Cardiology, have announced an unprecedented collaboration. The primary objective of this partnership is to deliver in-home cardiovascular care using Digital Therapeutics (DTx) in India. The joint effort aims to accelerate the application and adoption of DTx in the field of Cardiology within the country.
India is grappling with an alarming burden of cardiovascular disease and is projected to have the highest number of cardiac-related deaths worldwide by 2030. Heart diseases disproportionately affect Indians at a younger age, often presenting without warning signs. Studies have shown that Indians suffer from heart ailments at least ten years earlier than their Western counterparts, underscoring the urgent need for preventive and comprehensive care.
The collaboration between Lupin Digital Health and ACC signifies a monumental leap in transforming cardiac care in India. It marks the first-ever alliance between a Digital Therapeutics player in India and ACC, with the exclusive goal of providing comprehensive heart care. As part of this partnership, Lupin Digital Health will leverage ACC's CardioSmart platform, guidelines, and workbooks to offer guidance to healthcare professionals and caregivers. These valuable resources will be readily accessible to doctors, patients, and caregivers through Lupin Digital Health's Lyfe app and website, lyfe.in.
ACC's Chief Innovation Officer, Ami B. Bhatt, MD, FACC, expressed that this collaboration with Lupin Digital Health showcases their commitment to advancing equitable cardiovascular care on a global scale. It exemplifies how innovative partnerships can bring about transformative outcomes for patients in India. Rajeev Sibal, President – India Region Formulations, Lupin Limited, stated that India's extensive talent pool and widespread adoption of smartphone-based technology offer immense potential for leveraging Digital Therapeutics. Through this collaboration, the management of heart disease in India can be revolutionised, empowering healthcare professionals and caregivers to deliver effective care beyond the confines of hospitals.
Click here to read the original news story.